Norfloxacin EP Impurity H
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

105440-01-5Norfloxacin EP Impurity H

● In Stock

Catalogue No.:VL3030004
CAS No.:105440-01-5
Mol. Formula:C19H22FN3O5
Mol. Weight:391.39 g/mol

Additional information on CAS 105440-01-5

Parent drug

Norfloxacin

IUPAC Name

7-[4-(Ethoxycarbonyl)-1-piperazinyl]-1-ethyl-6-fluoro-1, 4-dihydro-4-oxo-3-quinolinecarboxylic Acid

Pharmacopoeial Synonyms

Norfloxacin Related Compound H

Other Synonyms

Norfloxacin N-Ethoxycarbonyl Impurity

Smiles

O=C(C1=CN(CC)C2=C(C=C(F)C(N3CCN(C(OCC)=O)CC3)=C2)C1=O)O

Inchl

InChI=1S/C19H22FN3O5/c1-3-21-11-13(18(25)26)17(24)12-9-14(20)16(10-15(12)21)22-5-7-23(8-6-22)19(27)28-4-2/h9-11H,3-8H2,1-2H3,(H,25,26)

Description

Norfloxacin EP Impurity H also referred to in pharmacopoeias as Norfloxacin Related Compound H, is a meticulously characterized reference standard. It adheres to stringent regulatory guidelines, including those established by USP, EMA, JP, and BP. This product plays a vital role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial manufacturing of Norfloxacin. Furthermore, it is accompanied by a comprehensive Structure Elucidation Report (SER), ensuring its accuracy and reliability across various analytical applications. Norfloxacin EP Impurity H (CAS No: 105440-01-5) or Norfloxacin N-Ethoxycarbonyl Impurity is an impurity present in the synthesis of Norfloxacin represents the first broad-spectrum fluoroquinolone that is usually used against urinary tract infections, it has been identified as the main product of its photodegradation.

References

Mielji, Branislava, et al. “Column High-Performance Liquid Chromatographic Determination of Norfloxacin and Its Main Impurities in Pharmaceuticals.” Journal of AOAC INTERNATIONAL, vol. 91, no. 2, Mar. 2008, pp. 332–38, https://doi.org/10.1093/jaoac/91.2.332.?

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url